Skip to main content
. 2021 May 4;9(5):456. doi: 10.3390/vaccines9050456

Table 3.

Recorded AEFIs and reporting rates, per sex.

Females (n = 412) Males (n = 369) p-Value
AEFI n Reporting Rate (95%CI) × 100 Enrolled n Reporting Rate (95%CI) × 100 Enrolled
Local reaction 240 58.3 (53.3–63.1) 138 41.9 (36.6–47.5) <0.0001
General malaise 79 19.2 (15.5–23.3) 35 10.6 (7.5–14.5) 0.001
Neurological symptoms 23 5.6 (3.6–8.3) 13 4.0 (2.1–6.7) 0.305
Fever/hyperpyrexia 16 3.9 (2.2–6.2) 5 1.5 (0.5–3.5) 0.054
Gastrointestinal disorder 6 1.5 (0.5–3.1) 3 0.5 (0.2–2.6) 0.501
Allergic reaction 1 0.2 (0.0–1.3) 1 0.3 (0.0–1.7) 0.873
At least one AEFI 270 65.5 (60.7–70.1) 160 48.6 (43.1–54.2) <0.0001